TYRA
Tyra Biosciences Inc

187
Mkt Cap
$1.78B
Volume
279.00
52W High
$35.71
52W Low
$6.42
PE Ratio
-17.72
TYRA Fundamentals
Price
$32.52
Prev Close
$33.31
Open
$32.02
50D MA
$29.13
Beta
1.34
Avg. Volume
698,249.40
EPS (Annual)
-$1.51
P/B
6.33
Rev/Employee
$0.00
$460.11
Loading...
Loading...
News
all
press releases
Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights
Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights...
PR Newswire·14h ago
News Placeholder
More News
News Placeholder
Tyra Biosciences Narrows Dabogratinib Focus, Teases Mid-Year NMIBC and 2H Achondroplasia Data
Tyra Biosciences (NASDAQ:TYRA) CEO Todd Harris said the company has narrowed its focus to what he described as the highest value opportunities for its selective FGFR3 inhibitor dabogratinib...
MarketBeat·1d ago
News Placeholder
Best Growth Stocks To Consider - February 25th
Teledyne Technologies, Prologis, Hamilton Lane, Ascendis Pharma A/S, Hercules Capital, Tyra Biosciences, and Trinity Capital are the seven Growth stocks to watch today, according to MarketBeat's...
MarketBeat·6d ago
News Placeholder
Promising Growth Stocks To Follow Today - February 24th
Prologis, Ascendis Pharma A/S, Teledyne Technologies, Hamilton Lane, Hercules Capital, Tyra Biosciences, and Trinity Capital are the seven Growth stocks to watch today, according to MarketBeat's...
MarketBeat·7d ago
News Placeholder
Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month High - What's Next?
Tyra Biosciences (NASDAQ:TYRA) Hits New 1-Year High - Here's What Happened...
MarketBeat·7d ago
News Placeholder
Tyra Biosciences Announces Poster Presentations at the 2026 ASCO Genitourinary (GU) Cancers Symposium
Tyra Biosciences Announces Poster Presentations at the 2026 ASCO Genitourinary (GU) Cancers Symposium Tyra Biosciences Announces Poster Presentations at the 2026 ASCO Genitourinary (GU) Cancers...
PR Newswire·8d ago
News Placeholder
Tyra Biosciences to Participate in Upcoming Investor Conferences
Tyra Biosciences to Participate in Upcoming Investor Conferences Tyra Biosciences to Participate in Upcoming Investor Conferences PR Newswire CARLSBAD, Calif., Feb. 19, 2026 CARLSBAD, Calif., Feb...
PR Newswire·12d ago
News Placeholder
Promising Growth Stocks To Watch Today - February 18th
Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Hercules Capital, Tyra Biosciences, and Trinity Capital are the seven Growth stocks to watch today, according to MarketBeat's...
MarketBeat·13d ago
News Placeholder
Wedbush Increases Tyra Biosciences (NASDAQ:TYRA) Price Target to $53.00
Wedbush raised their price target on Tyra Biosciences from $37.00 to $53.00 and gave the company an "outperform" rating in a report on Friday...
MarketBeat·18d ago
News Placeholder
Tyra Biosciences (NASDAQ:TYRA) Sets New 12-Month High - Time to Buy?
Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month High - Here's What Happened...
MarketBeat·19d ago
<
1
2
...
>

Latest TYRA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.